ALIGOS THERAPEUTICS INC COM NEW - Stock (ALGS)

CUSIP: 01626L105

Q1 2024 13F Holders as of 31 Mar 2024

Share change
+864,164
Put/Call ratio
0%
SEC-reported price per share
$0.98
Number of holders
48
Value change
+$1,762,088
Number of buys
24
Open additional details 1 more signal available
Number of sells
7

Security key

01626L105

Report period

Q1 2024

Institutions

48

Top holders

10

Ownership snapshot

Top reported holders of ALGS - ALIGOS THERAPEUTICS INC COM NEW - Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ROCHE HOLDING LTD
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5 13F Highest disclosed value: $4,537,693 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $4.54M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value Top 5
ARMISTICE CAPITAL, LLC $4.54M
EcoR1 Capital, LLC $4.24M
Deep Track Capital, LP $4.05M
Vivo Capital, LLC $2.36M
Alyeska Investment Group, L.P. $1.91M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ROCHE HOLDING LTD
3/4/5
10%+ Owner
—
denominator unverified
—
11,025,941 shares
— 25 Oct 2023
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$4,537,693
6,833,875 shares
— 31 Dec 2023
EcoR1 Capital, LLC
13F
Company
13F
—
denominator unverified
$4,242,607
6,389,468 shares
— 31 Dec 2023
Deep Track Capital, LP
13F
Company
13F
—
denominator unverified
$4,052,239
6,102,770 shares
— 31 Dec 2023
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$2,355,228
3,547,030 shares
— 31 Dec 2023
Alyeska Investment Group, L.P.
13F
Company
13F
—
denominator unverified
$1,913,791
2,882,216 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
48
Shares
46,213,782
Rows available
48
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q1 2024 holders
48
Holder diff
47
Investor Q1 2026 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2026 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .